NYSE · HIMSHealthcareOffices & Clinics — Doctors

Hims & Hers Health, Inc. (HIMS)

$24.06−9.75%
Close Nov 5, 2026 · split-adjusted
Nov 4, 2026$26.66▼ 37.70% in range
Nov 4, 2025Low $14.52 · High $43.73Nov 4, 2026
What changed · written from our data
As of Nov 5, 2026

Hims & Hers Health closed at $24.06 on Nov 5, down 9.75%, 45.0% below its 52-week closing high. Volume of 17.6M shares was 1.72× its 20-day average (above normal).

Split-adjusted performance: -18.6% over one month, -6.2% over six months, -43.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $753.21M, up 38.2% from a year earlier, with a net margin of -11.5%.

Short interest was 53.5M shares at the Oct 15 settlement, down 2.4% from the prior report (26.2% of float, 5.0 days to cover).

Market cap$5.61B233.3M shares
Revenue · quarter$753.2M+38.2% YoY
Diluted EPS$-0.37−317.6% YoY
P/E · TTM—P/S 2.2×
Net margin-11.5%Gross 63.8%
Dividend yieldNone
52-week range14.52 – 43.73−45.0% from high
Volume17.6M1.72× 20-day avg
Volatility · 60d71.6%Annualised
Short % of float26.2%5.0 days to cover
Net cash-$524.3MCash $841.0M
Next earnings—Not scheduled
Split-adjusted performance
1W −18.9%1M −18.6%3M −23.8%6M −6.2%YTD −25.9%1Y −43.8%3Y +302.3%5Y +204.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Offices & Clinics — Doctors

Percentile among 7 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −6.2%, revenue growth −2.5%, net margin −4.5%, P/E 10.5×.

Short interest

Details →
Shares short53.5M−2.4% vs prior
Days to cover5.0Settled Oct 15
% of float26.2%
Short vol. 10d57.5%of daily volume

Closest peers by size in Offices & Clinics — Doctors

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
HIMSHims & Hers Health$24.06−9.75%−6.2%+38.2%−11.5%—$5.61B
TDOCTeladoc Health$9.41−2.99%+35.2%−3.4%−4.5%—$1.72BCompare
STLNStarling Oncology$6.70−3.46%————$682.8MCompare
SBCSBC Medical Group Holdings Incorporated$5.02−5.64%+56.4%+13.4%21.7%10.5$516.3MCompare
LFMDLifeMD$2.29−6.53%−49.0%−3.5%−16.6%—$110.5MCompare
AIRSAirSculpt Technologies$1.44−15.29%−58.4%−2.5%−2.6%—$103.8MCompare
WSTNWestin Acquisition$10.23−0.29%————$80.9MCompare

Quick answers

What does Hims & Hers Health do?
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements.
What is HIMS's market cap?
$5.61B, based on the Nov 5 close of $24.06.
Does Hims & Hers Health pay a dividend?
No regular cash dividend has been paid in the last year.
How much of HIMS is sold short?
53.5M shares, 26.2% of float, as of Oct 15, 2026.
What sector is HIMS in?
Healthcare, in the Offices & Clinics — Doctors industry.

About Hims & Hers Health

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

HQ: San Francisco, CA2,442 employeesListed Jan 21, 2021forhims.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology